APC and breast cancer: It has been described that genetic alterations in Wnt pathway components, such as APC, β-catenin, AXIN2, and TCF7L2 are implicated in colorectal, melanoma, gastric, hepatocellular, and breast cancer (7, 8, 10–12, 37).